Changes in the intestinal microbiota have been linked to diabetes, obesity, IBD, and Clostridium 26 difficile-associated disease. Despite this, it remains unclear how the intestinal environment, set by ion transport, 27 affects luminal and mucosa-associated bacterial composition. Na 
affects luminal and mucosa-associated bacterial composition. Na terminal ileum organoids displayed increased fut2 and fucosylation, indicating that B. thetaiotaomicron alone 38 is sufficient for the increased fucosylation seen in vivo. These data demonstrate that loss of NHE3 alters the 39 intestinal environment leading to region-specific changes in bacteria and shed light on the growth requirements 40 3
Introduction: 48
The alteration of normal gut microbiota is known to play a role in a variety of complex diseases such as 49 obesity (85), (51), (52), (86), (2), (84) , (3), diabetes (9), (47), Inflammatory Bowel Disease (28), (30), (68), 50 (56), (70), Antibiotic-associated diarrhea (92) and Clostridium difficile-associated disease (14). These complex 51 diseases are increasing in frequency and are associated with significant health care costs. Although these 52 diseases each demonstrate dramatic shifts in the gut microbiota at the phylum level, it remains mechanistically 53 unclear how certain bacterial groups are able to proliferate and maintain an altered composition. It is well 54 documented that changes in the gut microbiota are able to impact epithelial ion transport (21), (53), (54), (8) . 55 However, little is known about the effect of epithelial ion transport processes on the intestinal microbiota. Ion 56 transporters are expressed in distinctive patterns based on their intestinal location, and are required for 57 maintaining intestinal homeostasis (80). Likewise, microbiota composition varies in total number and species 58 representation along the intestinal length (6). An understanding of the relationship of ion transport status to the 59 microbiota is important for a clear understanding of regional microbiota changes. 60
Transporter null mouse models offer the unique ability to examine the microbial populations and 61 epithelial cross-talk along the length of the intestine. We have used the Na Indianapolis, IN). At 6-8 weeks post weaning, terminal ileum (<10 cm proximal to the cecum, hereafter referred 02 to as ileum), cecum, and colon (proximal and distal) segments were collected from WT and NHE3 -/-
littermates. 03
Individual intestinal segments were flushed with PBS (pH 7.4) and mucosal scrapings collected as previously 04
described (29), (42), (20), (61) . Briefly, intestinal segments were flushed with 500 µl PBS. The segments were 05 then opened lengthwise, washed thoroughly with PBS and glass slides were used to scrape the epithelia and 06 mucus layer. Luminal flushes were processed for total DNA and mucosal scrapings were processed either for 07 total DNA or for RNA. Sample wet weight was determined and tissue homogenized with a Tissue Tearor 08 homogenizer (Biospec Products Inc, Bartlesville, OK) for 1 min. RNA was extracted and stored at - Fisher Scientific) broth at 37 °C in a shaking incubator. B. thetaiotaomicron and P. melaninogenica were grown 21 in TSB (Tryptone Soy broth; Thermo Fisher Scientific), R. productus and F. prausnitzii were grown in TYG 22 (Tryptone-Yeast extract-Glucose broth; Thermo Fisher Scientific), and Peptostreptococcus anaerobius was 23 grown in Brain-heart-infusion (BHI; Thermo Fisher Scientific) broth at 37 °C in a Coy Systems, dual-port 24 anaerobic chamber (Coy Lab Products, Grass Lake, MI). These cultures were used to generate qPCR standard 25
curves. 26
For characterization of the optimal [Na + ] for growth of B. thetaiotaomicron and Lactobacillus 27 acidophilus bacteria were grown in media where sodium chloride (NaCl) was either removed or replaced with 28 cesium chloride (CsCl) as previously described (12 -/-mouse terminal ileum, cecum, proximal and distal colon segments were fixed for 4 41 h at 4°C in Carnoy's fixative and embedded in paraffin. Serial 6-7 μm thick sections were applied to glass 42 slides and stained with hematoxylin and eosin (H&E) for intestine architecture. Goblet cells were analyzed 43 semi-quantitative by counting goblet cells per 5 regions of interest/slide, 3 slides, n=4 mice. Expression of 44 fucosyl glycoconjugates on the mucosal surface was examined using FITC-conjugated Ulex europaeus 45 agglutinin-1 (UEA-1, Vector Laboratories, Burlingame, CA) as previously described (41), (55). Briefly, 46 sections were deparaffinized, blocked with PBS containing 10% BSA, and stained with FITC-labeled lectin (107 μg/ml) for 1 h at room temperature. Sections were then washed three times in PBS, mounted using Vectashield 48 mounting medium with DAPI (Vector Laboratories), and analyzed by confocal laser scanning microscopy 49 (Zeiss LSM Confocal 710, Carl Zeiss, Germany). Digital images of slides were evaluated by tabulating mean 50 pixel intensity of the respective color channel on each image using Image J software (NIH). Five regions of 51 interests of fixed size per slide, 3 slides per mouse, and n=4 mice were used for semi-quantitation of stain 52
intensity. 53 54
Quantitative Real Time-PCR amplification of 16S sequences. Total DNA was isolated with the QIAamp 55 DNA Stool kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. The lysis 56 temperature was increased to 95°C and an incubation with lysozyme (10 mg/ml, 37°C for 30 min) was added to 57 improve bacterial cell lysis as previously described (13), (27), (67), (61). The abundance of total bacteria and 58 specific intestinal bacterial phyla, class, genus and species was measured by qPCR using a Step One Real Time 59 PCR machine (Applied Biosystems (ABI) Life Technologies, Grand Island, NY) with SYBR Green PCR master 60 mix (ABI) and bacteria-specific primers (Table 1) in a 20 µl final volume. Bacterial numbers were determined 61 using standard curves from the pure bacterial cultures as previously described (62) reported as the delta delta C T using GAPDH as the standard. Differences in mRNA expression were determined 70 by qRT-PCR and expressed as the ΔΔC T relative fold difference. Primers for fucosyltransferase and GAPDH 71 were used as previously described (57) Dissociated tissues were centrifuged at 150 x g for 10 minutes and embedded in Matrigel (BD Biosciences). 87
After the Matrigel was polymerized, Advanced DMEM/F12 medium supplemented with R-spondin 1 88 (500ng/ml R&D Minneapolis, MN), penicillin/streptomycin (100/100 U/ml), HEPES (10 mM), Glutamax (2 89 mM), N2 and B27 (Broomall, PA) was overlaid with Noggin (100 ng/ml, PeproTech, Rocky Hill, NJ) and EGF 90 (50 ng/ml, PeproTech) as previously described (69). 91
92
Organoid microinjection: We have previously used microinjection to inject cRNA into Xenopus oocytes (17), 93 (22). Given that the organiods are of similar size to Xenopus oocytes used for expression studies, a similar 94 technique to that used for oocytes (39) was used to inject the lumen of the growing organoids. Organoids 95 derived from terminal mouse ileum tissue ranging in size from 200 to 350 µm in approximate diameter (~5 days 96 after passage) were used. Injection needles were pulled on a horizontal bed puller (Sutter Instruments) and the9 tip ends broken under stereoscope view to obtain a tip diameter of ~10-15 μm. Microinjection was 98 accomplished using a Nanoject microinjector (Drummon Scientific Company, Broomall, PA Figure 2D . NHE3 -/-mice exhibited a higher 26 non-Cl anion gap than is seen in WT mice for all intestinal segments studied, representing increased bicarbonate 27 and/or SCFA content. In addition, the NHE3 -/-mice had increased pH in all segments ( In order to determine if total bacterial numbers were increased in correlation with increased intestinal 33 size, total DNA was extracted from luminal flushes and mucosal scrapings and analyzed by qPCR. As shown in 34 -/-mouse ileum, cecum, proximal colon and distal colon. These data indicate that there is 38 bacterial over-representation in most of the luminal and all the mucosa-associated bacterial populations. 39
To further characterize the luminal and mucosa-associated bacterial populations, the major intestinal 40 bacterial phyla were compared as a percentage of total bacteria by qPCR. As shown in the bacterial phyla 41 representation in Figure 4A and Table 3 Bacteroidetes, significant changes were observed in Proteobacteria in the colon (PC: 4.2% increase, DC: 2.5% 54 increase) and Actinobacteria in the cecum (3.2% increase) and colon (PC: 7.3% increase, DC: 5.2% increase). 55
These data demonstrate that the NHE3 -/-mouse mucosa-associated bacterial composition is significantly 56 transformed in response to altered ion transport status. These data also highlight the differences between the 57 luminal and mucosa-associated bacterial population representation. Taken together, our data indicate that the 58
NHE3
-/-mouse intestine exhibits significant region-specific changes in the luminal and mucosa-associated 59 bacterial population. 60 12
NHE3 -/-mice exhibit altered microbiota composition in the luminal and mucosa-associated bacteria at the 62 subgroup level. 63
The subgroups of Firmicutes and Bacteroidetes were further examined to determine the groups 64 responsible for the significant changes observed in the Bacteroidetes and Firmicutes phyla (Figure 4C and D) . 65
In the luminal population ( Figure 4C and Table 4 ), changes were observed in all NHE3 -/-intestinal segments. 66
From the phylum Firmicutes, C. coccoides cluster XIVa was decreased in all the NHE3 -/-segments (I: 13.7%, 67 C: 47.5%, PC: 9.1%, DC: 26.7%) and C. leptum cluster IV decreased in the cecum (8.0%) and colon (PC: 8.4%, 68 DC 13.8%). The Lactobacillus/Enterococcus group was increased only in the cecum (46.5%) and another 69
Firmicutes group was changed in the cecum (14.1% decrease) and colon (PC: 17.1% increase, DC: 18.3% 70 increase). From the phylum Bacteroidetes, Prevotella was increased in all NHE3 
segments. 78
In the mucosa-associated bacterial population ( Figure 4D and Table 4 (14.8%) and proximal colon (10.0%) while decreased in the distal colon (3.3%). These data indicate that, in the 86 mucosa-associated bacterial population, Clostridium clusters and Lactobacillus/Enterococcus groups are 87 responsible for the decrease in the Firmicutes phyla while the MIB group is largely responsible for the 88 significant increase in the Bacteroidetes phyla. 89
The genus Bacteroides makes up a substantial portion of Bacteroidetes in the gastrointestinal tract and 90 the species Bacteroides thetaiotaomicron is a well characterized Bacteroides member found in both the human 91 and mouse intestine (7), (10), (15), (58), (35), (40), (91 Figure 5B ). The data shows that B. thetaiotaomicron has optimal growth 10 at 43 mM Na Luminal B. thetaiotaomicron is able to secrete α-fucosidases which extract fucose residues from mucus 26 glycans (41), (91) and stimulates fut2 mRNA transcription and fucosyltransferase activity to increase mucus 27 fucosylation, which is used as an energy source by the bacterium (16), (41), (57). We hypothesized that 28 increased B. thetaiotaomicron in NHE3 -/-mouse terminal ileum would stimulate increased fucosylation, and 29 thus provide a positive nutrient feedback mechanism that would further enhance B. thetaiotaomicron growth. 30
To determine if B. thetaiotaomicron was altering host fucoysltransferase activity, we examined fut mRNA by 31 qRT-PCR. As shown in Figure 6A and B, no significant changes were observed in fut1 mRNA, however the 32 dominant form fut2 mRNA was increased in NHE3 (75), (76), (77), (79), (89), (1) Data presented herein also demonstrate that mucosa-associated bacterial populations respond more 16 dramatically to changes in sodium and pH caused by the loss of NHE3 than the luminal bacteria. It is probable 17 that the mucosa-associated bacteria might be more influenced by the host genetics as they are in closer physical 18 proximity to the host epithelia. However, clearly ion transport status affects both luminal and mucosa-associated 19 representation of bacteria. Dramatic changes in the mucosa-associated bacterial population are also observed in 20 mouse models with genetic host alterations (29), (67), (83), (5) -/-may make these mice vulnerable to subsequent pathogen 38 infection in other mouse facilities. However, for the mice housed at our University's animal facility, the 39 analysis of the gut microbiota are not complicated by an active, robust inflammatory response. Nevertheless, 40 careful comparative study of differences between similar mice with or without overt inflammation should prove 41 valuable in determining the key factors (e.g., bacterial species) leading to an inflammatory response or pathogen 42 suseptability. 43
NHE3 is also clinically relevant for analysis as it is a target of Clostridium difficile toxin B (36). C. 44
difficile is a leading cause of nosocomial enteric infections. According to the CDC, C. difficile affects over half 45 a million people in America yearly and the incidence of non-hospital acquired C. difficile infection is 46 increasing. Since NHE3 is involved in Na + and water regulation, a large percentage of C. difficile infected 47 patients suffer from diarrhea (46), (59). In humans, increased Bacteroidetes and decreased Firmicutes have been 48
shown to be associated with C. difficile associated disease (CDAD) (14), (92) . In mice infected with C. difficile, 49
increased Bacteroides coordinately occurred in the ileum (60). Such alterations resemble the microbial changes 50 observed in the NHE3 -/-mouse model. Thus, it is likely that C. difficile toxin B inhibition of NHE3 serves to 51 alter the intestinal microbiota and thus create a more suitable environment for C difficile infection. Further 52 studies are necessary, and underway, to determine if the changes in the gut microbiota seen in C. difficile-53 infection is predominately due to inhibition of NHE3 rather than C. difficile-bacterial interaction. Taken 54 together the results presented herein propose that ion transport plays a key role not only in regulating the 55 intestinal environment but also establishing bacterial niches. This can be clinically advantageous because a 56 number of ion transporter drugs could be used in various disease states to alter the intestinal environment 57 (regionally specific to transporter expression) in a manner that promotes or represses growth of certain bacterial 58 groups. Such therapy could potentially be used to rebalance the intestinal microbiota after a shift with 59 C.
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